Learning Objectives:

1.  Understand the methodologic considerations underlying trial emulation using observational data.

2.  Compare glucose-lowering drugs with respect to achieving and maintaining glycemic control (emulation of the GRADE trial).

3.  Compare glucose-lowering drugs with respect to reducing cardiovascular events in patients at moderate cardiovascular risk.

Session date: 
02/26/2024 - 5:00pm to 6:00pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Rozalina G. McCoy, M.D., M.S.